PLATFORM
A Revolutionary New Approach
Using machine learning, we create superior drugs by programming antibodies to become dynamic functional switches that affect biology in new ways.
Biolojic’s AI-designed antibodies provide a precise molecular effect, in the desired micro-environment, at the right time, leading to greater efficacy and lower toxicity, while maintaining impeccable developability, half-life, stability and safety of human antibodies.
![researchers-whiteboarding](https://uebiolojic.wpengine.com/wp-content/uploads/2023/06/researchers-whiteboarding-scaled.jpg)
PLATFORM
A Revolutionary New Approach
Using machine learning, we create superior drugs by programming antibodies to become dynamic functional switches that affect biology in new ways.
Biolojic’s AI-designed antibodies provide a precise molecular effect, in the desired micro-environment, at the right time, leading to greater efficacy and lower toxicity, while maintaining impeccable developability, half-life, stability and safety of human antibodies.
PIPELINE
Bringing novel technology to well-established biology
We’re on a mission to cure disease.
Our pipeline of computationally designed programmable antibodies focuses on autoimmune diseases and immuno-oncology.
We target well-understood, validated biological pathways. We use our technology to design smart antibodies that affect these pathways more precisely and can succeed where traditional drugs have failed.
![antibody-wide](https://uebiolojic.wpengine.com/wp-content/uploads/2023/06/antibody-wide-scaled.jpg)
PIPELINE
Bringing novel technology to well-established biology
We’re on a mission to cure disease.
Our pipeline of computationally designed programmable antibodies focuses on autoimmune diseases and immuno-oncology.
We target well-understood, validated biological pathways. We use our technology to design smart antibodies that affect these pathways more precisely and can succeed where traditional drugs have failed.